蒸汽压
23.3 mmHg ( 30 °C)
质量水平
方案
33-37% (by potassium permanganate, titration)
表单
liquid
包含
inhibitor
反应适用性
reagent type: oxidant
环保替代产品特性
Catalysis
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
浓度
35 wt. % in H2O
折射率
n20/D 1.357
沸点
126 °C
mp
−40 °C
密度
1.13 g/mL at 25 °C
环保替代产品分类
储存温度
2-8°C
SMILES字符串
OO
InChI
1S/H2O2/c1-2/h1-2H
InChI key
MHAJPDPJQMAIIY-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
过氧化氢溶液产品是35%的过氧化氢水溶液。它通常用作绿色氧化剂，并且是比其他氧化剂更好的选择，因为它具有高活性氧含量，且副产物是水。
We are committed to bringing you Greener Alternative Products, which adhere to one or more of the 12 Principles of Green Chemistry. This product has been enhanced for catalysis. Click here for more information.
应用
过氧化氢溶液用作：
- 在烷基吡啶的N-氧化中用作氧化剂。
- 是合成GO（石墨烯氧化物）纳米粉末的组分之一。
包装
溶剂用M瓶(M-Bottle for Solvents)
作为实验室试剂的全球领导者，我们始终如一地不断探索提高产品安全性的新方法。新开发4L溶剂瓶采用先进的密封技术消除漏液，让溶剂处理变得更加安全和便利。
了解所有最新设计！
作为实验室试剂的全球领导者，我们始终如一地不断探索提高产品安全性的新方法。新开发4L溶剂瓶采用先进的密封技术消除漏液，让溶剂处理变得更加安全和便利。
了解所有最新设计！
警示用语：
Danger
危险分类
Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
5.1B - Oxidizing hazardous materials
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
易制爆化学品
危险化学品
此项目有
Integrated thermodynamic and kinetic model of homogeneous catalytic N-oxidation processes
Wang J, et al.
AIChE Journal, 66(4), e16875-e16875 (2020)
V-, Mo-and W-containing layered double hydroxides as effective catalysts for mild oxidation of thioethers and thiophenes with H2O2
Maciuca AL, et al.
Catalysis Today, 138(1-2), 33-37 (2008)
Understanding the cross-linking reactions in highly oxidized graphene/epoxy nanocomposite systems
Vryonis O, et al.
Journal of Materials Science, 54(4), 3035-3051 (2019)
Shoichi Iriguchi et al.
Blood, 125(2), 370-382 (2014-10-29)
Although overexpression of T-bet, a master transcription factor in type-1 helper T lymphocytes, has been reported in several hematologic and immune diseases, its role in their pathogenesis is not fully understood. In the present study, we used transgenic model mice
James R Van Brocklyn et al.
Cancer research, 74(19), 5364-5370 (2014-08-12)
Glioblastoma remains a devastating disease for which novel therapies are urgently needed. Here, we report that the Aurora-A kinase inhibitor alisertib exhibits potent efficacy against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo. Many glioblastoma neurosphere cells treated
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持